DiaMedica Therapeutics (DMAC) Interest & Investment Income (2024 - 2026)
DiaMedica Therapeutics' Interest & Investment Income came in at $385,000 for Q2 2026, up 23.0% from $313,000 a year earlier but down 18.1% from the prior quarter.
Powered by 
Analysis
DiaMedica Therapeutics (DMAC) Interest & Investment Income (2024 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, DiaMedica Therapeutics reported Interest & Investment Income of $1.77 million, down 7.9% year-over-year; for FY2025, it came in at $1.67 million, down 27.5% from FY2024.
- Going back by year, Interest & Investment Income was $2.3 million in FY2024 (+17.9%) and $1.95 million in FY2023.
- The five-year range for quarterly Interest & Investment Income is $313,000 (Q2 2025) to $618,000 (Q3 2024).
- Year-over-year, Interest & Investment Income increased in two of the last six quarters, with an average decline of 13.5%.
- Business Quant data shows DMAC's Interest & Investment Income at $470,000 (Q1 2026), $472,000 (Q4 2025) and $440,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | DiaMedica Therapeutics | 443.81 Mn | 443.81 Mn | - | 385,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 385,000.00 |
| Mar 31, 2026 | 470,000.00 |
| Dec 31, 2025 | 472,000.00 |
| Sep 30, 2025 | 440,000.00 |
| Jun 30, 2025 | 313,000.00 |
| Mar 31, 2025 | 444,000.00 |
| Dec 31, 2024 | 543,000.00 |
| Sep 30, 2024 | 618,000.00 |
| Jun 30, 2024 | 524,000.00 |
| Mar 31, 2024 | 616,000.00 |
API Access
DiaMedica Therapeutics Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=DMAC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "DMAC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=DMAC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();